- Amylin Pharmaceuticals And Biocon Limited Enter A Global - BioResearch Online (press release)
- Amylin Pharmaceuticals and Biocon Limited Enter a Global ... - Reuters
- Advinus plans trials for novel diabetes drug - Business Standard
- Glenmark, Forest Say Their Drug Failed In Trials - Wall Street Journal
- Advinus Therapeutics seeks DCGI approval to conduct clinical trials - Livemint
Biocon inks pact with Amylin to develop diabetes therapy - Business Standard
Biocon inks pact with Amylin to develop diabetes therapyBusiness StandardBiocon would utilise its expertise to manufacture the compound and also leverage its experience in pre-clinical and clinical development of diabetes ...Biocon, Amylin Pharma tie up to develop new diabetes drugMoneycontrol.comBiocon, US firm to jointly make drug for diabetesBombay NewsBiocon & Amylin Pharmaceuticals Join Hands For Anti-Diabetes Drugindia-server.comPharmaceutical Business Reviewall 56 news articles »
